Semaglutide vs Tirzepatide: Which is Better for Weight Loss?

By jon — February 17, 2026

Comprehensive guide to semaglutide vs tirzepatide: which is better for weight loss. What you need to know before starting your treatment in 2026.

Semaglutide vs Tirzepatide — two names dominating the weight loss medication landscape. This comprehensive 2026 comparison breaks down the science, results, and real-world differences.

Head-to-Head: Clinical Trial Results

The SURMOUNT-5 trial directly compared tirzepatide (Zepbound) against semaglutide (Wegovy). Tirzepatide users lost 20.2% of body weight vs 13.7% for semaglutide — 47% more weight with tirzepatide.

Key Differences

• Semaglutide: Single-action GLP-1 agonist, extensive safety data, established cardiovascular benefits
• Tirzepatide: Dual GIP/GLP-1 agonist, superior weight loss, more potent appetite suppression

Which Is Better?

For pure weight loss efficacy, tirzepatide wins. Choose tirzepatide for maximum results; choose semaglutide for gradual progress with longer safety track record. Both require medical supervision.

Medically reviewed by Dr. Michael Mimlitz, MD (NPI 1508891870), Chief Physician of GOAL.MD. Physician-supervised telehealth. More at goal.md/blog.